Tuesday's Top Biotech & Medical Stocks

Health and Healthcare

Published: April 18, 2007 2:56 am

Biotechnology

NOVACEA, INC. [NOVC] +19.70%
CERAGENIX PHARMACUTL [CGXP.OB] +7.53%
NEURO-HITECH INC [NHPI.OB] +7.31%
TARGETED GENETICS CP [TGEN] +7.06%
INTROGEN THERAPEU [INGN] +5.74%

Diagnostic Substances

SCOLR PHARMA INC [DDD] +13.82%
PRESSURE BIOSCIENC [PBIO] +6.93%
EPICEPT CORPORATION [EPCT] +6.67%
INFINITY PHARMACEUTI [INFI] +3.16%
PONIARD PHARMA [PARD] +3.15%

Drug Delivery

COLUMBIA LABS INC [CBRX] +6.74%
BIOPROGRESS PLC [BPRG] +1.75%
NOVADEL PHARMA INC [NVD] +1.72%
ALKERMES INC [ALKS] +0.84%
GENEREX BIOTECH CORP [GNBT] +0.61%

Drug Manufacturers

ADVANCIS PHARMA CP [AVNC] +12.00%
TELIK INC [TELK] +9.17%
REGENERX BIOPHARM IN [RGN] +6.38%
VERTEX PHARMACEUT [VRTX] +5.85%
SOMAXON PHARMACEUTIC [SOMX] +5.15%

Drug Related Products

MEDICAL NUTRITN USA [MDNU.OB] +8.08%
TIENS BIOTECH GR USA [TBV] +3.68%
USANA HEALTH SCIEN [USNA] +3.28%
PRESTIGE BRAND HLGS [PBH] +2.50%
PERRIGO COMPANY [PRGO] +1.91%

Generic Drugs

CATALYST PHARMACEUTI [CPRX] +4.18%
HI-TECH PHARMACAL [HITK] +1.15%
WATSON PHARMACEUTCLS [WPI] +0.80%

Medical Appliances & Equipment

SPAN AMERICA MED S [SPAN] +16.49%
TRIMEDYNE INC [TMED.OB] +8.33%
IVIVI TECHNOLOGIES, [II] +7.55%
NON INVASIVE MONITORNG SYS NEW [NIMU.OB] +7.25%
EDAP TMS SA ADR [EDAP] +6.53%

Medical Instruments & Supplies

UROPLASTY INC [UPI] +12.15%
EP MEDSYSTEMS INC [EPMD] +10.20%
BIOFORCE NANOSCIENCE [BFNH.OB] +7.14%
XTENT INC [XTNT] +6.24%
CARDICA, INC. [CRDC] +5.00%

Medical Laboratories & Research

NEOGENOMICS INC [NGNM.OB] +3.03%
BIO-IMAGING TECH [BITI] +3.01%
PSYCHEMEDICS NEW [PMD] +2.60%
SPHERIX INC [SPEX] +1.67%
ERESEARCHTECHNOLOG [ERES] +1.12%

Smart Investors Are Quietly Loading Up on These “Dividend Legends”

If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.

Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.